
Weight Management & Metabolic
Transform your metabolism.
5 peptides in this category
Pharma Grade3ml vialThe Fat-Burning Fragment
AOD-9604 3.6mg
Lipolytic HGH fragment — targeted fat loss without diabetogenic effects
Clinical Uses
- Stubborn body fat reduction
- Visceral and subcutaneous fat loss
- Metabolic syndrome support
- Weight-loss plateau breaking
- Post-weight-loss composition refinement
Key Benefits
- Directly stimulates fat cell breakdown
- Does NOT raise blood sugar (unlike hGH)
- Does NOT suppress natural GH production
- Safe for long-term use
- No water retention or insulin resistance
How It Works
AOD-9604 binds beta-3 adrenergic receptors on adipocytes, raising cAMP and activating hormone-sensitive lipase to break down triglycerides while inhibiting lipogenesis.
Pharma Grade3ml vialHigh-Dose AOD
AOD-9604 15mg
High-dose AOD-9604 — advanced metabolic fat-burning protocol
Clinical Uses
- Advanced fat-loss protocols
- Extended metabolic optimisation
- Recomposition goals
Key Benefits
- Larger vial for uninterrupted 12-week protocols
- Same safe lipolytic mechanism
- Cost-efficient for longer cycles
How It Works
Same AOD-9604 fragment mechanism at higher concentration to support extended, uninterrupted fat-loss protocol continuity.
Pharma Grade3ml vialMitochondrial Metabolism
MOTS-C 30mg
Mitochondrial-derived peptide — metabolic flexibility and insulin sensitivity
Clinical Uses
- Metabolic syndrome and insulin resistance
- Type 2 diabetes support
- Obesity and visceral fat
- Exercise performance enhancement
- Mitochondrial dysfunction and fatigue
Key Benefits
- Activates AMPK master metabolic enzyme
- Exercise-mimetic metabolic effects
- Improves insulin sensitivity safely
- Reduces visceral fat, preserves lean mass
- Mitochondrially encoded — unique mechanism
How It Works
MOTS-c activates AMPK and regulates glucose and fatty acid metabolism, increasing GLUT4 translocation, activating PGC-1α and improving whole-body insulin sensitivity.
Pharma Grade3ml vialTriple GLP Agonist
Fat Burn Plus 15mg
Triple GLP-1 agonist stack — appetite control and weight management
Clinical Uses
- Medical weight loss and obesity
- Type 2 diabetes management
- Metabolic syndrome
- Cardiovascular risk reduction in obesity
- NAFLD support
Key Benefits
- Triple GLP-1/GIP/glucagon activity
- Reduces appetite centrally
- Improves glycemic control and HbA1c
- Reduces visceral and hepatic fat
- Cardiovascular protection
How It Works
Fat Burn Plus targets GLP-1, GIP and glucagon receptors: GLP-1R reduces appetite and slows gastric emptying; GIP-R enhances insulin and fat metabolism; glucagon-R raises energy expenditure.
Pharma Grade3ml vialMaximum GLP-1
Fat Burn Plus 40mg
High-dose Fat Burn Plus — maximum activity for significant weight loss
Clinical Uses
- Advanced medical weight loss
- Type 2 diabetes with significant obesity
- Extended weight management protocol
Key Benefits
- 40mg vial for extended treatment
- Outperforms semaglutide and tirzepatide
- Sustained 15–25% weight loss
- Cardiovascular and hepatic protection
How It Works
Same Fat Burn Plus triple-agonist mechanism; 40mg vial supports 3–4 months of weekly escalating dosing up to maximum therapeutic dose.
Confirm your eligibility
Start with a mandatory blood panel and physician consultation before any peptide protocol.
Book a consultation